In clinical cases of cardiotoxicity induced by PD-1 inhibitors, many patients exhibit abnormal cardiac collagen deposition in their cardiac tissues, and the deposition may manifest independently of myocarditis (Heinzerling et al., 2016), suggesting that PD-1 inhibitor-induced cardiac collagen remodeling is not exclusively secondary to inflammation. The gene discussed is PDCD1; the disease is myocarditis.